[Nicotinolytic action of antiparkinson drugs on rat diaphragm preparations].
D000109:Acetylcholine / Q000494:pharmacology; D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D003964:Diaphragm / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects*; D009121:Muscle Denervation; D009130:Muscle, Smooth / Q000187:drug effects* / Q000502:physiology; D009469:Neuromuscular Junction / Q000187:drug effects; D009538:Nicotine / Q000037:antagonists & inhibitors*; D010276:Parasympatholytics / Q000494:pharmacology*; D010640:Phenothiazines / Q000494:pharmacology; D010791:Phrenic Nerve / Q000502:physiology; D051381:Rats; D011955:Receptors, Drug; D012601:Scopolamine / Q000494:pharmacology*; D013997:Time Factors
D000470:Alkaloids; D010276:Parasympatholytics; D010640:Phenothiazines; D011955:Receptors, Drug; D009538:Nicotine; D001285:Atropine; D012601:Scopolamine; D000109:Acetylcholine
Nikotinolytische Wirkung der Antiparkinsonmittel am Rattenzwerchfellpräparat.